ATP7A silencing inhibits LOX activity in 4T1 breast cancer cell lines in an orthotopic mouse model of breast cancer, leading to the loss of Lox‐dependent metastasis mechanisms, including focal adhesion kinase phosphorylation and recruitment of bone marrow cells to the lung, thereby inhibiting tumor tumorigenesis and metastasis [22]. Here, LOX is linked to breast carcinoma.